STAT3 and colorectal carcinoma: These results collectively suggest that SA14 inhibits the acquisition of immune‐suppressive activities, CSC‐like properties and chemoresistance of CRC cells, at least in part, by suppressing STAT3‐mediated PD‐L1 expression.